Colombia INVIMA registration INVIMA 2024RD-0008801

AD-BIO PRUEBA DE EMBARAZO DE UN SOLO PASO

Name: AD-BIO PRUEBA DE EMBARAZO DE UN SOLO PASO — Colombia INVIMA registration INVIMA 2024RD-0008801
Creator: ANNAR DIAGNOSTICA IMPORT S.A.S.
Keywords: AD-BIO PRUEBA DE EMBARAZO DE UN SOLO PASO, INVIMA 2024RD-0008801, II, INVIMA registration

HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANYIIColombia INVIMAExpires August 14, 2034

VerifiedINVIMA · official registry

Device classification

Registered product (Spanish): AD-BIO PRUEBA DE EMBARAZO DE UN SOLO PASO
Risk class / Clase de riesgo: II
Product group (Spanish): REACTIVO DIAGNOSTICO

Registration information

Sanitary registration: INVIMA 2024RD-0008801
Expediente: 20285581
Status / Estado: Active
Expiry date: August 14, 2034

Registration holder / Titular

Name: ANNAR DIAGNOSTICA IMPORT S.A.S.

Associated party / Rol

Name: HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANY
Role: FABRICANTE
Country: ESTADOS UNIDOS DE AMÉRICA
Manufacturer: HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANY

About this record

Access comprehensive regulatory information for AD-BIO PRUEBA DE EMBARAZO DE UN SOLO PASO in the Colombia medical device market through Pure Global AI's free database. This II medical device is registered under INVIMA sanitary registration INVIMA 2024RD-0008801, held by ANNAR DIAGNOSTICA IMPORT S.A.S. and associated with HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANY (FABRICANTE). The registration expires on August 14, 2034.

This page provides complete registration details including product group (REACTIVO DIAGNOSTICO), holder and associated-party information, and regulatory data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.